October 27, 2016
Millions of Americans and their families struggle every day with the devastating effects of Alzheimer’s, Parkinson’s and Huntington’s diseases.
October 1, 2016
Millions of Americans and their families deal with the debilitating effects of neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and Huntington’s.…
September 16, 2016
Along with other advocacy, education and health care organizations, the Institute for Patient Access wrote to the Institute for Clinical and Economic Review this week offering 12 suggestions on how to improve its value framework. The letter responded to ICER’s request for feedback as it prepares to update its framework for 2017.
August 30, 2016
A new analysis calls for drastic price reductions for PCSK9 inhibitors, breakthrough lipid-lowering medications. Data published in the Journal of the American Medical Association suggest that the treatments would need to be reduced to two-thirds their current price to meet analysts’ cost-effectiveness thresholds.
July 28, 2016
July 28 marks World Hepatitis Day, part of the World Health Organization’s effort to eliminate hepatitis B and C by 2030.
July 22, 2016
Patients with Alzhe.imer’s or Parkinson’s disease may have a new source of hope: cancer drugs
June 30, 2016
Starting July 1, patients battling hepatitis C in Delaware will have newfound access to direct-acting antiviral cures – a victory now shared with patients in New York, Pennsylvania, Florida and Washington.
April 11, 2016
A physician tells a story in the Alliance for Patient Access’ oncology working group white paper about attending the funeral of one of his cancer patients.
April 7, 2016
Health insurers who deny patients access to hepatitis C cures could be violating federal law, explains an April 5 letter from the Alliance for Patient Access and The AIDS Institute to Florida’s insurance commissioner.
February 18, 2016
Patients who battle both hepatitis C and a health plan that denies coverage for the cure have a new recourse: legal action.
